Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating how atrial fibrosis affects atrial fibrillation risk in stroke patients

Official title: Impact of Atrial Fibrosis Surface Area on the Occurrence of Atrial Fibrillation in Patients With Ischemic Stroke of Undetermined Origin: a Prospective Cardiac MRI Pilot Study.

Run by Centre Hospitalier Universitaire Dijon · NCT06047782 · Data updated 2026-11-12

This study is trying to see if measuring heart tissue damage can help identify stroke patients who are at risk for developing atrial fibrillation and might benefit from better monitoring.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment157 (estimated)
SponsorCentre Hospitalier Universitaire Dijon
Academic / other
Locations1 site (Dijon)
StatusRecruiting
StartedJanuary 31, 2024
Main results expectedJanuary 2031
Study endsJanuary 2031
Registry record updatedOctober 26, 2026
Trial IDNCT06047782 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults who have experienced a cryptogenic ischemic stroke within the last 30 days and are scheduled for an implantable loop recorder.

Probably not a fit

Patients who have a history of atrial fibrillation or contraindications to MRI will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the relationship between the surface area of atrial fibrosis and the occurrence of atrial fibrillation in patients who have experienced an ischemic stroke of unknown origin. It utilizes cardiac MRI imaging to assess the left atrium and aims to improve the selection process for patients who may benefit from implantable loop recorders. By identifying patients at higher risk for atrial fibrillation, the study seeks to enhance long-term monitoring and treatment strategies. The study involves patients who have had a cryptogenic ischemic stroke within the last 30 days and are scheduled for loop recorder implantation.

Why it matters

Potential benefit: If successful, this study could lead to more targeted and effective monitoring of atrial fibrillation in stroke patients, potentially reducing the risk of future strokes.

How similar studies have gone: While the use of cardiac MRI in this context is innovative, similar studies have shown promise in identifying atrial fibrillation risk factors in stroke patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient who has provided free, written and informed consent
* Patient of legal age
* Patient with cryptogenic ischemic stroke within 30 days of inclusion, documented by brain imaging (cerebral angioscan or cerebral MRI)
* Patients scheduled for implantable loop recorder implantation within 3 months of ischemic stroke in search of silent AF:

  * cryptogenic ischemic stroke or stroke with probable cardioembolic cause
  * no history of atrial fibrillation
  * no long-term anticoagulant therapy
  * with life expectancy \>12 months

Exclusion Criteria:

* Person not affiliated to national health insurance
* Person under legal protection (curatorship, guardianship)
* Person under court order
* Pregnant, parturient or breast-feeding
* Adult unable to give consent
* Patient diagnosed with AF during stroke assessment
* Patient with a contraindication to MRI or gadolinium injection:

  * Severe renal impairment (\<30ml/min Cockroft clearance due to gadolinium injection)
  * Claustrophobia / contraindication to MRI (metal implant not MRI compatible)
  * History of hypersensitivity to gadoteric acid or gadolinium-based contrast agents, and to meglumine
  * Uncontrolled asthma

Where it's running

  • Chu Dijon Bourgogne
    Dijon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.